Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Endometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agents.

Moxley KM, McMeekin DS.

Oncologist. 2010;15(10):1026-33. doi: 10.1634/theoncologist.2010-0087. Epub 2010 Oct 7. Review.

2.

Advances in the management of endometrial adenocarcinoma. A review.

Irvin WP, Rice LW, Berkowitz RS.

J Reprod Med. 2002 Mar;47(3):173-89; discussion 189-90. Review.

PMID:
11933681
3.

[Chemotherapy of metastatic endometrial carcinoma. Review of the literature].

Pierga JY, Dieras V, Paraiso D, Pouillart P.

Bull Cancer. 1995 Dec;82(12):1005-18. Review. French.

PMID:
8745666
4.

[Chemotherapy of endometrial cancer revisited].

Fehr MK, Wight E, Haller U.

Gynakol Geburtshilfliche Rundsch. 1999;39(3):110-20. Review. German.

PMID:
10420053
5.

Systemic therapy in metastatic or recurrent endometrial cancer.

Pectasides D, Pectasides E, Economopoulos T.

Cancer Treat Rev. 2007 Apr;33(2):177-90. Epub 2006 Dec 29. Review.

PMID:
17196749
6.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
7.

The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.

Alvarez Secord A, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, Bland A, Rutledge TL, Berchuck A, Clarke-Pearson DL, Gehrig PA.

Gynecol Oncol. 2007 Nov;107(2):285-91. Epub 2007 Aug 6.

PMID:
17688923
8.

Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma.

Humber C, Tierney J, Symonds P, Collingwood M, Kirwan J, Williams C, Green J.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003915. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD003915.

PMID:
16235346
9.

Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma.

Humber C, Tierney J, Symonds P, Collingwood M, Kirwan J, Williams C, Green J.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003915. Review. Update in: Cochrane Database Syst Rev. 2005;(4):CD003915.

PMID:
16034916
10.

Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.

Murphy KT, Rotmensch J, Yamada SD, Mundt AJ.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1272-6. Review.

PMID:
12654437
11.

Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.

Mundt AJ, Murphy KT, Rotmensch J, Waggoner SE, Yamada SD, Connell PP.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1154-60.

PMID:
11483324
12.

Locally recurrent endometrial cancer: a case report.

Tantravahi SK, Werner TL.

J Natl Compr Canc Netw. 2012 Apr;10(4):442-5.

PMID:
22491044
13.

Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy.

Mundt AJ, McBride R, Rotmensch J, Waggoner SE, Yamada SD, Connell PP.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1145-53.

PMID:
11483323
14.

Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.

Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S, Kudo R; Japanese Gynecologic Oncology Group.

Gynecol Oncol. 2008 Jan;108(1):226-33. Epub 2007 Nov 9.

PMID:
17996926
15.

[Effects of postoperative chemotherapy on the prognosis of patients with high-risk early stage endometrial cancer].

Wen HW, Tian F, Ma L, Liao QP.

Zhonghua Fu Chan Ke Za Zhi. 2009 Mar;44(3):196-9. Chinese.

PMID:
19570445
16.
17.

Postoperative adjuvant chemotherapy with cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin, pirarubicin) for endometrial cancer.

Yahata H, Hirakawa T, Fujita T, Ariyoshi K, Sonoda K, Amada S, Kobayashi H, Nakano H.

Int J Clin Oncol. 2004 Aug;9(4):317-21.

PMID:
15375709
18.

Adjuvant treatment for stage IIIC endometrial cancer: options and controversies.

Shah PH, Kudrimoti M, Feddock J, Randall M.

Gynecol Oncol. 2011 Sep;122(3):675-83. doi: 10.1016/j.ygyno.2011.05.018. Epub 2011 Jun 12. Review.

PMID:
21664661
19.

Prolonged remission of endometrial cancer with paclitaxel and carboplatin.

Vasuratna A, Kudelka AP, Edwards CL, Wootipoom V, Verschraegen CF, Charnsangavej C, Kavanagh JJ.

Anticancer Drugs. 1998 Mar;9(3):283-5.

PMID:
9625439
20.

Is there any place for cytotoxic chemotherapy in endometrial cancer?

Steer C, Harper P.

Best Pract Res Clin Obstet Gynaecol. 2001 Jun;15(3):447-67. Review.

PMID:
11476565
Items per page

Supplemental Content

Write to the Help Desk